Current opinion on nanotoxicology

DARU, Journal of Pharmaceutical Sciences

Volumn 20, Issue 1, 2012, Pages

  Pourmand, Ali ^a   Abdollahi, Mohammad ^b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Current opinion; Nanotechnology; Nanotoxicology

Indexed keywords

CARBON NANOTUBE; NANOPARTICLE;

ENDOCYTOSIS; NANOANALYSIS; NANOTECHNOLOGY; NANOTOXICOLOGY; OXIDATIVE STRESS; REVIEW;

EID: 84871880190     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-20-95     Document Type: Review

References (25)

1. Meyer M, Persson O, Power Y, Mapping excellence in nanotechnologies: Preparatory study (Nanotechnology expert group and Eurotech data) European Commission: Report to the European Commission 2001
2. The Project on Emerging Nanotechnologies Consumer Products Inventory http://www.nanotechproject.org/inventories/consumer/, accessed Nov. 2012.
3. Analytical methods to assess nanoparticle toxicity. Marquis BJ, Love SA, Braun KL, Haynes CL, Analyst 2009 134 425 439 10.1039/b818082b 19238274
4. Application of nanomedicine in emergency medicine; point-of-care testing and drug delivery in twenty-first century. Pourmand A, Pourmand MR, Wang J, Shesser R, DARU 2012 20 26 1 3 23226110
5. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Tran CL, Buchanan D, Cullen RT, Searl A, Jones AD, Donaldson K, Inhal Toxicol 2000 12 1113 1126 10.1080/08958370050166796 11114784
6. Inflammation caused by particles and fibres. Donaldson K, Tran CL, Inhal Toxicol 2002 14 5 27 10.1080/089583701753338613 12122558 (Pubitemid 34094358)
7. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, Alexander A, Toxicol Sci 2006 92 5 22 10.1093/toxsci/kfj130 16484287 (Pubitemid 43985785)
8. Chaudhry Q, Blackburn J, Floyd P, Final Report: A scoping study to identify gaps in environmental regulation for the products and applications of nanotechnologies http://www.defra.gov.uk/science/project-data/DocumentLibrary/ CB01075/CB01075-3373-FRP.doc.
9. A prudent approach to nanotechnology environmental, health and safety risks. Nordan MM, Holman MW, Ind Biotechnol 2005 1 146 149 10.1089/ind.2005.1. 146
10. Eghbalnia M, Electrochemical and Raman investigation of pyrite and chalcopyrite oxidation https://circle.ubc.ca/handle/2429/41999.
11. Aitken RJ, Creely KS, Tran CL, Nanoparticles: An occupational hygiene review, Volume 274 of Research report http://www.hse.gov.uk/research/rrpdf/ rr274.pdf.
12. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Oberdorster G, Oberdorster E, Oberdorster J, Environ Health Perspect 2005 113 823 839 10.1289/ehp.7339 16002369 (Pubitemid 40984181)
13. Prevention of malathion-induced depletion of cardiac cells mitochondrial energy and free radical damage by a magnetic magnesium-carrying nanoparticle. Shafiee H, Mohammadi H, Rezayat SM, Hosseini A, Baeeri M, Hassani S, Mohammadirad A, Bayrami Z, Abdollahi M, Toxicol Mech Methods 2010 20 538 543 10.3109/15376516.2010.518173 20919798
14. The safety of nanosized particles in titanium dioxide and zinc oxideebased sunscreens. Newman M, Stotland M, Ellis J, J Am Acad Dermatol 2009 61 685 692 10.1016/j.jaad.2009.02.051 19646780
15. Toxicological hazards of inhaled nanoparticles-potential implications for drug delivery. Borm PJ, Kreyling W, J Nanosci Nanotechnol 2004 4 521 531 10.1166/jnn.2004.081 15503438 (Pubitemid 39387404)
16. Fundamental properties of oligo double-stranded DNA/single-walled carbon nanotube nanobiohybrids. Yamamoto Y, Fujigaya T, Niidome Y, Nakashima N, Nanoscale 2010 2 1767 1772 10.1039/c0nr00145g 20820708
17. Using carbon nanotubes to induce micronuclei and double strand breaks of the DNA in human cells. Cveticanin J, Joksic G, Leskovac A, Petrovic S, Sobot AV, Neskovic O, Nanotechnology 2010 21 015102 10.1088/0957-4484/21/1/015102 19946169
18. Ultrafine particles in the urban air: to the respiratory tract-and beyond? Oberdorster G, Utell MJ, Environ Health Perspect 2002 110 440 A441 10.1289/ehp.110-a440 12153769
19. Drug delivery and nanoparticles: applications and hazards. De Jong WH, Borm PJ, Int J Nanomedicine 2008 3 133 149 18686775 (Pubitemid 352042401)
20. Long circulating microparticulate drug carriers. Stolnik S, Illum L, Davis SS, Adv Drug Deliv Rev 1995 16 195 214 10.1016/0169-409X(95)00025-3
21. The polyoxyethylene/polyoxypropylene block copolymer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. Porter CJ, Moghimi SM, Illum L, Davis SS, FEBS Lett 1992 305 63 66
22. Nanoparticulate systems for brain delivery of drugs. Kreuter J, Adv Drug Deliv Rev 2001 47 65 81 10.1016/S0169-409X(00)00122-8 11251246 (Pubitemid 32209233)
23. A novel formulation for superparamagnetic iron oxide (SPIO) particle enhancing MR lymphography: comparison of physicochemical properties and the in vivo behavior. Lind K, Kresse M, Debus NP, Müller RH, J Drug Target 2002 10 221 230 10.1080/10611860290022651 12075823 (Pubitemid 34467291)
24. Is there a shift to "active" nanostructures? Subramanian V, Youtie J, Porter AL, Shapira P, J Nanopart Res 2010 12 1 10 10.1007/s11051-009- 9729-4 21170117
25. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Song Y, Li X, Du X, Eur Respir J 2009 34 559 567 10.1183/09031936.00178308 19696157